We can’t stop everyone from getting breast cancer, but we hope to prevent as many as possible. What can you do.
Professor Andrew Shelling
Andrew has worked in one the world's leading research laboratories in Oxford, at the Institute of Molecular Medicine, on the genetics of ovarian cancer. During his three years in Oxford, he was able to experience scientific research at the highest level, and to teach medical students at the prestigious Christ Church College, Oxford University, before returning back to Auckland to establish his own research laboratory,
Andrew has served as Deputy Head of Department of Obstetrics and Gynaecology (2001-2013), President of the New Zealand branch of the Human Genetics Society of Australasia (2002-2004), Deputy-Chairperson of the Advisory Committee for Assisted Reproductive Technologies (2006-2012), Director of the Bachelor of Medical Sciences Honours programme (2008-2016) and as Associate Editor for the Human Reproduction journal (2004-2013). Andrew is currently the Associate Dean (Research), Associate Dean (Performance Based Research Fund), on the Editorial Board for the Human Fertility journal and the Clinical Genetics journal, and is a Trustee for the Nurture Foundation for Reproductive Research.
Research areas of interest are in understanding the molecular changes that occur during the development of human disease, particularly those occurring in breast and ovarian cancer, and reproductive disorders.
In 2013, Breast Cancer Cure formed part of the Breast Cancer Research Partnership with The Health Research Council of New Zealand (HRC), and has since jointly funded $1.4 million worth of new research projects.
prevention, earlier detection, predictive and prognostic diagnosis, appropriate and tailored treatment.